Determining the affinities of high-affinity antibodies using KinExA and surface plasmon resonance

ABSTRACTAccurate and efficient affinity measurement techniques are essential for the biophysical characterization of therapeutic monoclonal antibodies, one of the fastest growing drug classes. Surface plasmon resonance (SPR) is widely used for determining antibody affinity, but does not perform well...

Full description

Saved in:
Bibliographic Details
Main Authors: M. Frank Erasmus (Author), Molly Dovner (Author), Fortunato Ferrara (Author), Sara D'Angelo (Author), André A. Teixeira (Author), Camila Leal-Lopes (Author), Laura Spector (Author), Elizabeth Hopkins (Author), Andrew R. M. Bradbury (Author)
Format: Book
Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8d9d6973ecb14fbf9cc087829f04f11c
042 |a dc 
100 1 0 |a M. Frank Erasmus  |e author 
700 1 0 |a Molly Dovner  |e author 
700 1 0 |a Fortunato Ferrara  |e author 
700 1 0 |a Sara D'Angelo  |e author 
700 1 0 |a André A. Teixeira  |e author 
700 1 0 |a Camila Leal-Lopes  |e author 
700 1 0 |a Laura Spector  |e author 
700 1 0 |a Elizabeth Hopkins  |e author 
700 1 0 |a Andrew R. M. Bradbury  |e author 
245 0 0 |a Determining the affinities of high-affinity antibodies using KinExA and surface plasmon resonance 
260 |b Taylor & Francis Group,   |c 2023-12-01T00:00:00Z. 
500 |a 10.1080/19420862.2023.2291209 
500 |a 1942-0870 
500 |a 1942-0862 
520 |a ABSTRACTAccurate and efficient affinity measurement techniques are essential for the biophysical characterization of therapeutic monoclonal antibodies, one of the fastest growing drug classes. Surface plasmon resonance (SPR) is widely used for determining antibody affinity, but does not perform well with extremely high affinity (low picomolar to femtomolar range) molecules. In this study, we compare the SPR-based Carterra LSA and the kinetic exclusion assay (KinExA) for measuring the affinities of 48 antibodies generated against the SARS-CoV-2 receptor-binding domain. These data reveal that high-affinity antibodies can be generated straight from selections using high-quality in vitro library platforms with 54% correspondence between affinities measured using LSA and KinExA. Generally, where there was a 2-fold or greater difference between LSA and KinExA, KinExA reported that affinities were tighter. We highlight the differences between LSA and KinExA, identifying the benefits and pitfalls of each in terms of dynamic range and throughput. Furthermore, we demonstrate for the first time that single-point screening with KinExA can significantly improve throughput while maintaining a strong correlation with full binding curve equilibrium measurements, enabling the accurate rank-ordering of clones with exceptionally tight binding properties. 
546 |a EN 
690 |a Antibody 
690 |a drug discovery 
690 |a antibody therapeutics 
690 |a surface plasmon resonance 
690 |a kinetic exclusion assay 
690 |a antibody characterization 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Immunologic diseases. Allergy 
690 |a RC581-607 
655 7 |a article  |2 local 
786 0 |n mAbs, Vol 15, Iss 1 (2023) 
787 0 |n https://www.tandfonline.com/doi/10.1080/19420862.2023.2291209 
787 0 |n https://doaj.org/toc/1942-0862 
787 0 |n https://doaj.org/toc/1942-0870 
856 4 1 |u https://doaj.org/article/8d9d6973ecb14fbf9cc087829f04f11c  |z Connect to this object online.